Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Histopathology. 2016 Nov 15;70(3):402–411. doi: 10.1111/his.13076

Table 2.

ROS1 IHC positive cases

Case # KRAS/EGFR/ALK status ROS1 IHC - % cells positive ROS1 IHC - Intensity ROS1 IHC - H score (% x intensity) ROS1 FISH
Retrospective Cohort
1 KRAS & EGFR unknown/ALK− 90% 3+ 244 + (single set of split signals)
2–81 23 KRAS+, 13 EGFR+, 4 PIK3CA+, 2 MET+, 1 ALK+, 1 BRAF+, 1 FGFR1+, 1 HRAS+, 6 unknown 5–80% (mean =24) 1+ 5–80 (mean=24) -
82–90 3 KRAS+, 5 EGFR+, 0 unknown 20–78 (mean 40) 2+ 40–120 (mean 79) -
Prospective cohort
1 All Negative 100% 3+ 300 + (classic split signal pattern)
2 All Negative 100% 3+ 300 + (classic split signal pattern)
3 All Negative 100% 3+ 300 + (single set of split signals)
4 KRAS unknown
EGFR−/ALK−
100% 3+ 300 + (classic split signal pattern)
5 KRAS unknown
EGFR−/ALK−
100% 3+ 300 + (isolated 3′ green signal pattern)
6 All Negative 100% 3+ 300 + (classic split signal pattern)
7 All Negative 90% 3+ 270 + (isolated 3′ green signal pattern)
8 All Negative 100% 3+ 300 + (classic split signal pattern)
9 All Negative 100% 3+ 300 + (classic split signal pattern)
10 All Negative 90% 3+ 270 +(isolated 3′ green signal pattern)
11 All Negative 100% 3+ 300 + (classic split signal pattern)
12 All Negative 100% 3+ 300 + (isolated 3′ green signal pattern)
13 KRAS unknown
EGFR−/ALK−
100% 3+ 300 − (isolated 5′ red signal pattern)
14 All Negative 25% 3+ 75 -
15 All Negative 80% 3+ 280 -
16 EGFR+/KRAS−/ALK− 33% 3+ 99 -
17 EGFR+/KRAS−/ALK− 20% 2+ 40 -
18 KRAS unknown
EGFR−/ALK−
30% 3+ 90 -
19 KRAS unknown
EGFR−/ALK−
20% 3+ 60 -